IBRANCE: payments to doctors
Payments that named IBRANCE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.4M
- Providers
- 10,964
- Transactions
- 64,541
- Average per transaction
- $83
The per-transaction average — $83 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,964 providers the average total is $489, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $5,303,977 | 98.8% |
| PBG Puerto RICO LLC | $44,427 | 0.8% |
| Whitehall International Inc | $7,165 | 0.1% |
| Array Biopharma Inc | $4,953 | 0.1% |
| Pfizer Pharmaceuticals LLC | $2,323 | 0.0% |
| Pfizer S.A. | $2,200 | 0.0% |
| Pfizer ZONA Franca, S.A. | $861 | 0.0% |
| Pfizer Pharma GmbH | $499 | 0.0% |
| Pfizer Corporation HONG KONG Limited | $359 | 0.0% |
| Medivation Services LLC | $62 | 0.0% |